Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | VideoGame Development | Contact

Cervical Cancer Animation / Cervical Cancer Illustrations


Human Papillomavirus Animations (HPV Animation / HPV Illustrations)


Vaccine Animations / Vaccine Illustrations- Human Papillomavirus illustrations


Medical Animation Studio can produce cervical cancer animation and cervical cancer illustrations for medical marketing companies. HPV animations and Vaccine animations use 3d medical illustrations – vaccine illustrations also cervical cancer illustrations.  
Human papillomavirus animation and human papillomvirus.illustrations Trade show companies use HPV animations, Cancer illustrations turning them into stunning scientific animations for presentations.  3D custom graphics used in interactive graphics 3d medical graphics.  Custom cervical cancer animations and cervical cancer illustrations 3d medical.

 

Human papillomavirus animation and human papillomvirus illustrations 

 

Dr Nano
Advaxis Phase I Survival Update
Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy...
More Funding Needed For Breast, Cervical Cancer Detection Program, Advocates Say
During an event to mark its 20th anniversary, advocates of the National Breast and Cervical Cancer Early Detection Program on Tuesday expressed frustration that the program has not been extended to more low-income women and urged Congress to increase funding, CQ HealthBeat reports...
Experts Concerned About Increase In HPV-Related Head And Neck Cancers
The human papillomavirus increasingly is being identified as the cause of head and neck cancers, prompting some physicians to guess that the genesis of the cancers might be oral sex, the Raleigh News & Observer reports. David Brizel, an oncologist at Duke University who specializes in head and neck cancers, said, "A third of head and neck cancers we see nowadays are [related to] HPV...
Zetiq Reports CE Conformity For Its Cervical Cancer Diagnostic Kit
Zetiq Technologies Ltd. ("Zetiq"), a subsidiary of Bio-Light Ltd. (TASE: BOLT), reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens...
Einstein Receives $4 Million To Test HPV Microbicide
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from the seaweed derivative carrageenan in preventing new HPV infections in women...
Exceptions To Pap Screening In Adolescents HPV Testing Not Recommended
Most adolescent girls should wait until they turn 21 to have their first Pap test, but those who have HIV and others with weakened immune systems should begin routine cervical cancer screening right away, according to The American College of Obstetricians and Gynecologists...
Study Links Consistent Condom Use To Lower HPV Risk Among Men
Men who consistently use condoms during sex are less likely to contract human papillomavirus than those who do not, according to a study published in the Journal of Infectious Diseases, Reuters reports. There are more than 100 strains of HPV, some of which can cause genital warts and lead to cervical cancer in women and anal and penile cancers in men...
Study Confirms Vaccine Could Prevent More Cases Of Cervical Cancers Than Previously Expected
Scientists at the Health Protection Agency (HPA), the University of Manchester and the Manchester Royal Infirmary have found that the cervical cancer vaccine could prevent more cases of the disease in England than previously thought, according to a study published in the British Journal of Cancer. This could potentially reduce the annual number of cases from around 3000 to less than 700...
Also In Global Health News: Afghan Aid Priorities; Temperature-Sensitive Vaccine; WHO Flu Preparedness; HPV Vaccine In India; More
Afghan Government Tells Foreign Donors How Aid Should Be Spent "The Afghan government wants foreign donors to focus 80 percent of the billions of dollars flowing into the country on priority projects it believes are key to pulling the country out of poverty and turmoil, Afghan officials said," the Associated Press reports...
Prospects Uncertain For Calif. Breast, Cervical; Cancer Screening Program
California's ongoing budget crisis is raising doubts about the viability of the state's Every Woman Counts breast and cervical cancer screening program for low-income women, the San Jose Mercury News reports (Theriault, San Jose Mercury News, 7/10)...
A*STAR Scientists Score "Hat-Trick" Against Cancer
A*STAR scientists have made three separate groundbreaking discoveries in fight against cancer Scientists from Singapore's Agency of Science, Technology and Research (A*STAR) have made three successive breakthroughs in key areas of cancer research...
Study From First Latin American Country To Implement National HPV Testing Program Shows Successful Cervical Cancer Control
A study released "online first" in Cancer Causes & Control demonstrates that human papillomavirus (HPV) testing, using QIAGEN's digene® HPV Test, improved cervical cancer control compared to routine Pap (cytology) testing among 50,000 women across Mexico, the first country in Latin America to implement a national screening program for the high-risk (HR) types of HPV that ca...
IncellDx Announces Successful Presentation Of Complete Solution For Cervical Cancer Screening At International HPV Meeting In Montreal
IncellDx, Inc., a sponsor at the International HPV meeting this week in Montreal, Canada, announces that two presentations at the meeting demonstrated that IncellDx's HPV OncoTect® E6/E7 mRNA kit greatly increases specificity compared to other HPV tests and was successfully used in a large clinical trial in women under 30 years of age...
New Data Demonstrate Zyclara™ Imiquimod 3.75% Superior To Placebo For Treatment Of External Genital Warts (EGW)
Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more efficacious than placebo, according to data presented at the annual Human Papillomavirus (HPV) Conference in Montreal, July 3 - 8. Investigators found that efficacy was greatest for imiquimod 3...
Aiming For An HPV Vaccine Cheap Enough For The Developing World
Vaccine manufacturers in India and other developing countries may be able to produce a lower-cost HPV vaccine in spite of the complicated array of patent protections on the technology, say researchers at the Duke Institute for Genome Sciences & Policy...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2010
Content Management / Website Design by Tresware